SE9201930D0 - Gastric antibacterial treatment - Google Patents
Gastric antibacterial treatmentInfo
- Publication number
- SE9201930D0 SE9201930D0 SE9201930A SE9201930A SE9201930D0 SE 9201930 D0 SE9201930 D0 SE 9201930D0 SE 9201930 A SE9201930 A SE 9201930A SE 9201930 A SE9201930 A SE 9201930A SE 9201930 D0 SE9201930 D0 SE 9201930D0
- Authority
- SE
- Sweden
- Prior art keywords
- gastric
- antibacterial treatment
- treatment
- infections
- processes
- Prior art date
Links
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201930A SE9201930D0 (sv) | 1992-06-24 | 1992-06-24 | Gastric antibacterial treatment |
IS4030A IS4030A (is) | 1992-06-24 | 1993-06-09 | Lyf, ætlað til inntöku, sem hefur bakteríueyðandiáhrif í maga, aðferð við framleiðslu þess og notkun |
PCT/SE1993/000521 WO1994000112A1 (en) | 1992-06-24 | 1993-06-11 | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
AU45178/93A AU4517893A (en) | 1992-06-24 | 1993-06-11 | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
SI9300330A SI9300330A (sl) | 1992-06-24 | 1993-06-23 | Peroralna formulacija za zelodcno protibakterijsko terapijo, postopek izdelave in uporaba |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201930A SE9201930D0 (sv) | 1992-06-24 | 1992-06-24 | Gastric antibacterial treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9201930D0 true SE9201930D0 (sv) | 1992-06-24 |
Family
ID=20386583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9201930A SE9201930D0 (sv) | 1992-06-24 | 1992-06-24 | Gastric antibacterial treatment |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU4517893A (sv) |
IS (1) | IS4030A (sv) |
SE (1) | SE9201930D0 (sv) |
SI (1) | SI9300330A (sv) |
WO (1) | WO1994000112A1 (sv) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE192932T1 (de) * | 1993-09-09 | 2000-06-15 | Takeda Chemical Industries Ltd | Formulierung enthaltend einen antibakteriellen und einen antiulcus wirkstoff |
WO1995026753A1 (fr) * | 1994-04-01 | 1995-10-12 | Tsumura & Co. | Procede de production de comprimes a liberation prolongee et de comprimes enteriques |
UA41995C2 (uk) * | 1994-05-06 | 2001-10-15 | Пфайзер Інк. | Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти ) |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
IL119627A (en) | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
SE9700885D0 (sv) * | 1997-03-12 | 1997-03-12 | Astra Ab | New pharmaceutical formulation |
CA2282531A1 (en) | 1997-03-25 | 1998-10-01 | Takeda Chemical Industries, Ltd. | Gastrointestinal mucosa-adherent pharmaceutical composition |
GB9710699D0 (en) * | 1997-05-24 | 1997-07-16 | Danbiosyst Uk | Gastro-retentive controlled release system |
US6694692B2 (en) | 1998-10-16 | 2004-02-24 | Francesco Piccone | Modular formwork elements and assembly |
MXPA05010636A (es) * | 2003-04-04 | 2005-12-12 | Pharmacia Corp | Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada. |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2552632A1 (en) * | 2004-01-06 | 2005-07-21 | Panacea Biotec Ltd. | Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2578845A1 (en) * | 2004-08-27 | 2006-03-23 | Spherics, Inc. | Multi-layer tablets and bioadhesive dosage forms |
CN101410109A (zh) * | 2006-03-24 | 2009-04-15 | 万能药生物有限公司 | 抗生素的调节释放组合物及其制备方法 |
RU2006132127A (ru) * | 2006-09-06 | 2008-03-20 | Государственное Учреждение Научный Центр Здоровьядетей Российской Академии Медицинских Наук (Гу Нцзд Рамн) (Ru) | Применение нифуроксазида в качестве компонента комбинированной лекарственной терапии заболеваний, ассоциированных с helicobacter pylori, и способ лечения, направленный на эрадикацию возбудителя |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
CA2085342A1 (en) * | 1990-06-14 | 1991-12-15 | Milton R. Kaplan | Stable aqueous drug suspensions |
IE914307A1 (en) * | 1990-12-11 | 1992-06-17 | Brocades Pharma Bv | Heterocyclic carboxylic esters, methods for their¹preparation and their use for the preparation of¹gastro-intestinal medicines |
-
1992
- 1992-06-24 SE SE9201930A patent/SE9201930D0/sv unknown
-
1993
- 1993-06-09 IS IS4030A patent/IS4030A/is unknown
- 1993-06-11 AU AU45178/93A patent/AU4517893A/en not_active Abandoned
- 1993-06-11 WO PCT/SE1993/000521 patent/WO1994000112A1/en active Application Filing
- 1993-06-23 SI SI9300330A patent/SI9300330A/sl unknown
Also Published As
Publication number | Publication date |
---|---|
SI9300330A (sl) | 1993-12-31 |
AU4517893A (en) | 1994-01-24 |
WO1994000112A1 (en) | 1994-01-06 |
IS4030A (is) | 1993-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9201930D0 (sv) | Gastric antibacterial treatment | |
ITBO910476A0 (it) | -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali. | |
DE69802260D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen | |
MA23533A1 (fr) | Formes posologiques d'azithromycine | |
MX9101046A (es) | Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre | |
DE69838986D1 (de) | Polypeptide, deren herstellung und verwendung | |
DK0667148T3 (da) | Peroralt farmaceutisk præparat, der udløses i den nedre del af mavetarmkanalen | |
DE68905939D1 (de) | Infektionsresistente zusammensetzungen, medizinische geraete und oberflaechen und verfahren zur herstellung und gebrauch derselben. | |
ZA895936B (en) | Pharmaceutical compositions comprising selected lactobacillus strains | |
SE0102315D0 (sv) | Compounds | |
NO910213D0 (no) | Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan. | |
AU1937395A (en) | Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic | |
ZA87164B (en) | Opthlamic use of quinolone and naphthyridine antibiotics | |
ITRM920900A0 (it) | Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale. | |
AU2000255628A1 (en) | Formulation comprising thymol useful in the treatment of drug resistant bacterial infections | |
HUP9600455A3 (en) | Use of quinoxalines combined with protease-inhibiting compounds for producing pharmaceutical compositions for treating aids and/or hiv infections | |
DE69108143T2 (de) | Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten. | |
ATE87476T1 (de) | Fluessige orale formulierung. | |
TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
TR199802270A2 (xx) | S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri. | |
EA200000568A2 (ru) | Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы | |
WO1999020259A3 (en) | Compositions containing thiamphenicol and diclofenac | |
ATE71299T1 (de) | Pharmazeutische zubereitung zur behandlung bakterieller infektionen. | |
DE69737088D1 (de) | Therapeutisches agens zur behandlung von fiv infektionen | |
ATE145333T1 (de) | Hirudin enthaltende orale arzneimittel |